Welcome to our dedicated page for Sibannac news (Ticker: SNNC), a resource for investors and traders seeking the latest updates and insights on Sibannac stock.
Sibannac Inc. develops lifestyle and wellness businesses tied to next-generation consumer products, plant-medicine tourism, and consciousness-focused media. The OTC-quoted Nevada corporation has described product activity in mainstream supplements, Amanita mushrooms, Kratom, and hemp-derived cannabis products, alongside wholesale and retail distribution.
Company news centers on Starwalker Cafe content, Starwalker Journeys retreats, regulated botanical wellness experiences, co-marketing relationships with consciousness-media partners, and marketing initiatives intended to expand market visibility. Updates also reference regulatory and research developments affecting botanical wellness and plant-medicine travel.
Summary not available.
Summary not available.
Summary not available.
Sibannac, Inc. (OTC Pink: SNNC) announced that CEO David Mersky will be interviewed by Jane King on New to the Street. The discussion will focus on the company's entry into the alternative wellness sector. The interview is scheduled to air on Newsmax on February 20, 2022, at 10:00 AM EST and on Fox Business on February 21, 2022, at 10:30 PM PST.
Investors should consider that the statements made in the interview may include forward-looking statements subject to risks and uncertainties.
Sibannac, Inc. (OTC Pink: SNNC) has announced the upcoming launch of its next-generation wellness brand aimed at holistic medical practitioners. The brand will target over 400,000 practitioners in the U.S., offering proprietary formulations that address various health concerns such as autoimmune conditions, hormone imbalances, and anxiety. Leveraging the experience of the Lifetime Branding team, the flagship brand aims for significant market penetration through leading practitioner sales platforms. CEO David Mersky expressed enthusiasm for this strategically timed launch.
Sibannac, Inc. (OTC Pink: SNNC) continues its transformation into a multi-faceted wellness brand, operating from its Scottsdale facility. The company focuses on contract manufacturing and aims to build a sustainable brand in the alternative wellness space. Key initiatives include developing Kratom products and leveraging partnerships for enhanced marketing and distribution. Additionally, the firm has secured a licensing agreement for Copper 1 raw material, aiding its product formulation and meeting consumer health needs. Sibannac is also pursuing clinical trials for Copper 1 while expanding its market reach.
Sibannac, Inc. (OTC Pink: SNNC) announced a Letter of Intent with SPUR Biotech for a potential Joint Venture focusing on plant-based vaccines derived from lettuce. This partnership aims to develop vaccines that require no refrigeration, can be administered orally, and utilize sustainable farming practices. The deal is structured to avoid dilution of common stock, with initial efforts directed towards clinical trials for regulatory approval. CEO David Mersky highlighted that this collaboration could enhance Sibannac's health and wellness offerings and improve brand credibility.
Sibannac, Inc. (OTC Pink: SNNC) has announced its collaboration with a technology firm to develop wearable healthcare technology. This innovation utilizes discreet sensors and an app for personalized healthcare assessments. Sibannac intends to acquire this firm, facilitating research, development, and marketing. Additionally, the company is set to launch a new consumer brand focusing on anxiety, sleep, and pain relief products. Research on Kratom products is underway, targeting high-quality offerings for both their brand and white-label clients.
Sibannac, Inc. (OTC Pink: SNNC) announced a debt-for-equity agreement with Lifetime Branding Collaborative, resulting in the forgiveness of $400,000 in debt in exchange for 2 million shares of Preferred B stock. This move strengthens their commitment to wellness branding and incurs no immediate dilution. CEO David Mersky will also forgive accrued compensation for equity. The company is poised to manufacture Delta-8 THC products following recent legal clarifications, enhancing product offerings significantly.
Sibannac, Inc. (OTC Pink: SNNC) has achieved a 100% increase in share price over the past year and is focusing on expanding its white label manufacturing and launching a new wellness brand in 2022. The company plans to retire $400,000 in fees owed to branding partner Lifetime Branding through a debt forgiveness agreement. Additionally, Sibannac will manufacture Delta-8 THC products following a DEA ruling classifying it under the 2018 Farm Bill. A new retail location is set to open in downtown Scottsdale, and an awareness campaign is planned for the upcoming year.